Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-29

FDA Approved: EVOTAZ — Original Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approved EVOTAZ, a fixed-dose combination of atazanavir and cobicistat for the treatment of HIV-1 infection, with cobicistat acting as a pharmacokinetic boo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EVOTAZ (atazanavir and cobicistat)

Snippet

ORIG AP for EVOTAZ (ATAZANAVIR AND COBICISTAT)